Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    Loans
    Loans
    HomeNewsBusinessMarketsBuy Aurobindo Pharma, target Rs 850: Abhishek Mondal

    Buy Aurobindo Pharma, target Rs 850: Abhishek Mondal

    traders can buy the stock around current levels and add on dips around Rs 750-755 with a stop loss below Rs 720 for the target of Rs 850, says Abhishek Mondal of Guiness Securities.

    Moneycontrol Contributor
    October 31, 2018 / 11:46 IST
    Answer: Nostrum (File imagDivis Laboratories share price performance in FY18: Up 75 percent | FY19: Up 56 percent | FY20: Up 17 percent.e)
       
       
      26 Aug, 2025 12:21
      Volume
      Todays L/H
      More
      Abhishek Mondal

      In daily scale, Aurobindo Pharma has given a breakout from its flag pattern above Rs 770-772 levels on Monday with higher volumes.

      In the daily scale, Relative strength index (RSI) showing sideways to positive momentum and (+) DI trading above (-) DI whereas Stochastic %K continuously trading above %D, which indicates limited downside for the stock.

      Based on the above observations, traders can buy the stock around current levels and add on dips around Rs 750-755 with a stop loss below Rs 720 (closing) for the target of Rs 850.

      Disclaimer: The author is Research Analyst, Guiness Securities. The views and investment tips expressed by investment experts on Moneycontrol are his own, and not that of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.
      Moneycontrol Contributor
      Moneycontrol Contributor
      first published: Oct 31, 2018 11:46 am

      Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

      Subscribe to Tech Newsletters

      • On Saturdays

        Find the best of Al News in one place, specially curated for you every weekend.

      • Daily-Weekdays

        Stay on top of the latest tech trends and biggest startup news.

      Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347